Molecular Imaging: Page 30

Best Cyclotron Systems merges with Best ABT
By AuntMinnieEurope.com staff writers
Best ABT Molecular Imaging and Best Cyclotron Systems, both part of TeamBest Global Companies, recently merged into one entity.
January 9, 2022
2020 04 22 17 11 4900 Business Handshake Man 400
PET with blood test can assist in Alzheimer's clinical trials
By Will Morton
An international group led by Swedish researchers has found that PET imaging combined with a new blood test for Alzheimer's disease may be the best approach to identify people to participate in clinical drug trials.
January 2, 2022
2021 12 23 19 29 0282 2022 01 03 Tau Pet Brain Stages 400
PET/MRI scanner damaged by copper wire theft
By AuntMinnieEurope.com staff writers
A 4-million-pound (4.74 million euros) PET/MRI scanner at Newcastle University's Centre for In-Vivo Imaging in the U.K. has been damaged beyond repair due to the theft of copper wire from a nearby electricity substation, according to a BBC report.
December 22, 2021
2021 12 23 22 58 4660 Pet Mri 400
Hybrid imaging can predict survival outcome in melanoma cases
By Will Morton
A new Austrian study has found that PET/CT scans of metastatic melanoma patients who receive immunotherapy drugs can help predict survival outcome. The team from Salzburg published its results on 12 December in the European Journal of Radiology.
December 15, 2021
2021 12 16 00 38 6234 2021 12 15 Fdg Uptake Melanoma 20211216000259
Meet the EuroMinnies 2022 semifinal candidates
The list of candidates for the fourth edition of the EuroMinnies awards scheme is now available, following the nominations made by the members of AuntMinnieEurope.com. A new category for radiographers has been introduced this year.
December 15, 2021
2018 11 08 21 06 6728 Euro Minnies Logo 400
U.K. releases guidance on molecular radiotherapy
By AuntMinnieEurope.com staff writers
Changes in the U.K. healthcare systems will be required for patients to fully benefit from recent advances in molecular radiotherapy, according to U.K. medical societies.
December 12, 2021
2020 06 16 15 21 7966 Radiotherapy Uk Image 400
ITM, Navigo collaborate on radioisotope
By AuntMinnieEurope.com staff writers
German radiopharmaceutical firm ITM Isotope Technologies Munich and Navigo Proteins are teaming up to develop a fibroblast activation protein-targeted radiopharmaceutical program for the treatment of solid tumors.
December 2, 2021
2018 12 11 00 02 7009 Atom Nuclear Lab 400
PET/MRI proves valuable in difficult epilepsy cases
By Will Morton
PET/MRI can identify the brain lesions causing seizures in patients with drug-resistant epilepsy when standard approaches fail, according to research published on 20 November in Epilepsy Research. The findings may offer hope for patients for whom surgery is often the only treatment option.w
November 30, 2021
Comparison between PET+MRI (A) and PET/MRI (B); axial and coronal plane, PET alone and co-registered on MRI. The subject is a 17-year-old female with drug-resistant epilepsy since the age of 2 years; nocturnal frontal seizures (3 times per night), left frontotemporal ictal onset, negative MRI (3 tesla). Her first PET examination co-registered on MRI at 11 years considered negative; PET/MRI six years later, showing a focal hypometabolism involving the posterior part of the left orbitofrontal cortex, relative involvement of the adjacent cortex (gyrus rectus, anterior part of the left inferior frontal gyrus) and the temporal pole. This hypometabolism was retrospectively found on the previous PET but remained inconclusive. Note that the co-registration was imperfect on this examination, whereas it was almost perfect on the PET/MRI, allowing a better confidence for the visual analysis. The patient was operated on without invasive monitoring despite a negative MRI scan. Surgery was based on a PET/MR guided cortical resection, including the hypometabolic orbitofrontal cortex and the adjacent inferior frontal gyrus, in front of Broca area. FCD type 2 A was found in the cortical specimen. The patient has been seizure-free for two years and the use of antiepileptic drugs greatly reduced. Image courtesy of Epilepsy Research.
Clarity hits milestone in study of radiopharmaceutical
By AuntMinnieEurope.com staff writers
Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer.
November 14, 2021
2021 11 10 21 17 4908 2021 11 10 Image 1 Clarity Pharma Se Cu Re 20211110213127
Goh provides glimpse into future world of hybrid imaging
By Frances Rylands-Monk
How can the clinical potential of PET/MRI be unlocked? What challenges lie ahead? Cancer imaging expert Prof. Vicky Goh took out her crystal ball and provided some insight into the future role of PET/MRI and how both modalities can be integrated effectively. She also touched on PET/CT.
November 8, 2021
2021 11 09 00 45 4896 2021 11 09 Future Of Pet Mri Screencapture4 20211109001217
EANM publishes guide on principles and practice of PET/CT
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine's Technologists Committee has published a free, practical 100-page guide outlining recent advancements in radioisotope imaging, with a special emphasis on PET/CT techniques.
November 4, 2021
2019 10 23 17 43 2588 Pet Ct Machine 400
Finnish group uses PET to assess brain changes in obesity
By AuntMinnieEurope.com staff writers
Changes in the brain, including an altered function of neural networks that regulate appetite and satiety, can be seen before people become obese, researchers from Finland have reported in a study involving PET.
November 3, 2021
2019 02 12 00 17 8657 Finland Flag 400
Previous Page
Page 30 of 120
Next Page